Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the Unaudited Standalone ....
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals has informed BSE that a meeting of its Board of Directors is scheduled on Thursday, February 12, 2026, at 10:30 AM at the registered office in Amritsar, Punjab. The primary agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended December 31, 2025 (Q3 FY26). The trading window for designated persons and connected parties remains closed and will stay closed until 48 hours after the results are declared. The intimation is filed under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine regulatory intimation ahead of the Q3 FY26 results announcement. Investors should watch the actual results on/after February 12 for any material impact on the stock. No immediate price-moving information is contained in this filing.